20240051917. HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF simplified abstract (BIOGEN MA INC.)

From WikiPatents
Jump to navigation Jump to search

HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

Organization Name

BIOGEN MA INC.

Inventor(s)

Anton Fran Joseph Fliri of Stonington CT (US)

Randall J. Galluschun of Lebanon CT (US)

Christopher John O'donnell of Mystic CT (US)

Jacob Bradley Schwarz of San Ramon CA (US)

Barbara Eileen Segelstein of Gales Ferry CT (US)

HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240051917 titled 'HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

Simplified Explanation

The abstract of the patent application states that the invention is directed towards compositions containing compounds of formula i and their uses.

  • The patent application is focused on compositions containing compounds of formula i and their applications.
  • The invention is described in the specification of the patent application.
  • The compounds of formula i have specific properties or characteristics that make them useful in various applications.
  • The patent application aims to protect the intellectual property rights of the inventor regarding the compositions and uses of the compounds of formula i.

Potential Applications of this Technology

  • Pharmaceutical industry: The compounds of formula i may have potential applications in the development of new drugs or therapies.
  • Chemical industry: The compositions containing compounds of formula i may be used in the production of various chemical products.
  • Biotechnology: The compounds of formula i may have applications in biotechnological processes or research.

Problems Solved by this Technology

  • Lack of effective compounds: The invention may provide new compounds that can address certain problems or challenges in specific industries.
  • Limited options: The compounds of formula i may offer alternative solutions to existing problems in various fields.
  • Specific requirements: The invention may fulfill specific requirements or criteria that are not met by currently available compounds or compositions.

Benefits of this Technology

  • Improved efficacy: The compounds of formula i may exhibit enhanced efficacy compared to existing compounds.
  • Versatility: The compositions containing compounds of formula i may have multiple applications across different industries.
  • Intellectual property protection: The patent application ensures that the inventor has exclusive rights to the compositions and uses of the compounds of formula i.


Original Abstract Submitted

as defined in the specification. the invention is also directed to compositions containing and uses of the compounds of formula i.